Host factors associated with outcome from primary human immunodeficiency virus-1 infection

被引:6
作者
Telenti, Amalio [1 ,2 ]
Carrington, Mary [3 ]
机构
[1] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland
[2] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland
[3] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
genome; HLA antigens; KIR receptors; viral load;
D O I
10.1097/COH.0b013e3282f18ac0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The early events in human immunodeficiency virus-1 infection are increasingly recognized as critical for the overall evolution of the disease. Viral and host factors interact to establish a point of equilibrium defined by the viral set point. This review highlights new opportunities in the understanding of the genetic and genomic determinants of those early events. Recent findings The field of human immunodeficiency virus host genetics is shifting from the measure of long-term consequences of infection to the analysis of quantitative biological endpoints of viral control, with particular attention on the earliest events as study phenotypes. The field has also been enriched by a better understanding of the determinant and complex role of human leukocyte antigen and killer cell immunoglobulin-like-receptor variation, and by the completion of the first genome-wide study of determinants of human immunodeficiency virus-1 replication. The genome analysis highlights the central influence of acquired immunity in viral control, and provides an extensive catalogue of novel gene candidates. Summary Host genetics and genomic analyses of precise quantitative study phenotypes offer an unprecedented opportunity to dissect critical steps in human immunodeficiency virus-1 pathogenesis.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [11] Acute Human Immunodeficiency Virus Infection
    Richey, Lauren E.
    Halperin, Jason
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 345 (02) : 136 - 142
  • [12] Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection
    Nakai, Hidetaka
    Kawamura, Yoshiki
    Sugata, Ken
    Sugiyama, Hiroko
    Enomoto, Yoshihiko
    Asano, Yoshizo
    Ihira, Masaru
    Ohashi, Masahiro
    Kato, Tomochika
    Yoshikawa, Tetsushi
    MICROBIOLOGY AND IMMUNOLOGY, 2012, 56 (02) : 93 - 98
  • [13] Comparison of serum and plasma viral RNA measurements in primary and chronic human immunodeficiency virus type 1 infection
    Rodriguez, RJ
    Dayhoff, DE
    Chang, G
    Cassol, SA
    Birx, DL
    Artenstein, AW
    Michael, NL
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (01): : 49 - 53
  • [14] Management of Human Immunodeficiency Virus in Primary Care
    Sell, Jarrett K.
    PRIMARY CARE, 2013, 40 (03): : 589 - +
  • [15] Prediction of Human Immunodeficiency Virus-1 Viral Load from CD4 Cell Count Using Artificial Neural Networks
    Kamalanand, Krishnamurthy
    Jawahar, Ponnuswamy Mannar
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2015, 5 (03) : 641 - 646
  • [16] Public health and eradication of infection by the Human Immunodeficiency Virus
    Verdejo Ortes, Jose
    REVISTA ESPANOLA DE SALUD PUBLICA, 2019, 93
  • [17] Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection
    Kalapila, Aley G.
    Marrazzo, Jeanne
    MEDICAL CLINICS OF NORTH AMERICA, 2016, 100 (04) : 927 - 950
  • [18] APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection
    Gourraud, P. A.
    Karaouni, A.
    Woo, J. M.
    Schmidt, T.
    Oksenberg, J. R.
    Hecht, F. M.
    Liegler, T. J.
    Barbour, J. D.
    HUMAN IMMUNOLOGY, 2011, 72 (03) : 207 - 212
  • [19] BK virus infection in human immunodeficiency virus-infected patients
    J. Ledesma
    P. Muñoz
    D. Garcia de Viedma
    I. Cabrero
    B. Loeches
    P. Montilla
    P. Gijon
    B. Rodriguez-Sanchez
    E. Bouza
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1531 - 1535
  • [20] Immunopathogenic mechanisms of human immunodeficiency virus infection.
    Gluckman, JC
    REVUE DE MEDECINE INTERNE, 1996, 17 (04): : 313 - 320